Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow BJGP Open on Instagram
  • Visit bjgp open on Bluesky
  • Blog
Intended for Healthcare Professionals
BJGP Open

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
Research

The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study

Behnaz Schofield, Clive Gregory, Micaela Gal, David Gillespie, Gurudutt Naik, Alastair Hay and Nick Francis
BJGP Open 2020; 4 (2): bjgpopen20X101006. DOI: https://doi.org/10.3399/bjgpopen20X101006
Behnaz Schofield
1 Senior Research Fellow, Faculty of Health and Applied Sciences, University of West of England, Bristol, UK
MSc, MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: behnaz.schofield{at}uwe.ac.uk
Clive Gregory
2 Research Manager, School of Medicine Neuadd Meirionnydd, University Hospital of Wales, Cardiff, UK
BSc, MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Micaela Gal
3 Institute Translation Manager, School of Medicine Neuadd Meirionnydd, University Hospital of Wales, Cardiff, UK
BSc, DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Gillespie
4 Deputy Director of Infection, Inflammation & Immunity Trials and Senior Research Fellow, Centre for Trials Research Neuadd Meirionnydd, University Hospital of Wales, Cardiff, UK
BSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gurudutt Naik
5 Honorary Clinical Lecturer, School of Medicine Neuadd Meirionnydd, University Hospital of Wales, Cardiff, UK
MB MS, MPH, MRCSed, MRCGP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alastair Hay
6 Professor of Primary Care, Centre for Academic Primary Care Bristol Medical School: Population Health Science, University of Bristol, Bristol, UK
MBChB, MD, MRCP, MRCGP, DCH(RCP), FHEA, DFFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Francis
7 Professor of Primary Care Research, School of Medicine Neuadd Meirionnydd, University Hospital of Wales, Cardiff, UK
BA, PhD, MD, MRCGP, PGD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Presenting symptoms and their severity
  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Box plot of calprotectin levels (natural logarithm transformed) for cases (split by group A rapid streptococcus test status) and controls
  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Box plot of calprotectin levels (natural logarithm transformed) by FeverPAIN total score
  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Box plot of calprotectin levels (natural logarithm transformed) by Centor score

Tables

  • Figures
  • ParticipantsInclusion criteriaExclusion criteria
    Patients
    1. Previously healthy adults (aged ≥18 years)

    2. Acute illness (duration ≤7 days)

    3. Presenting with sore throat as the main symptom and have a FeverPAIN score ≥2

    1. Patients not consenting

    2. Inability to obtain throat swabs

    3. Treating clinician believes that the most likely cause of the sore throat is something other than a bacterial or viral infection (that is, thrush, trauma, referred pain, gastro-oesophageal reflux disease)

    4. Patients who are known or thought to have significant immune compromise (such as those with leukaemia, lymphoma, myeloma, AIDS, asplenia, congenital immunodeficiency, undergoing chemotherapy, or recent corticosteroid therapy).

    5. Patients on immunosuppressive therapy (including oral and inhaled steroids)

    6. Active haematological malignancy

    7. Undergoing treatment for cancer or has a life-limiting illness (for example, end-stage chronic obstructive pulmonary disease [COPD])

    8. Currently pregnant

    9. Have been on antibiotics for this illness

    Healthy volunteers1. Healthy adults (aged ≥18 years) who have had no sore throat symptoms for >4 days
    1. Patients not consenting

    2. Patients currently taking antibiotics

    3. Inability to obtain throat swabs

    4. Active haematological malignancy (undergoing treatment for cancer or has a life-limiting illness [for example, end-stage COPD)])

    5. Currently pregnant

    • View popup
    Table 1. Demographic characteristics of recruited participants
    Cases (n = 30)Controls (n = 10)
    n % n %
    Male 413.3550.0
    Female 2686.7550.0
    Mean SD Min–max Mean SD Min–max
    Age, years 32.311.7417–6446.810.1029–61
    • Min–max = minimum to maximum.

    • View popup
    Table 2. Clinical features of cases
    Cases (n = 30)
    Median Lower to upper quartile Minimum to maximum
    Duration of current illness, days 32–31–21
    Duration of sore throat, days 32–41–7
    FeverPAIN total score 33–42–5
    Symptom severity a Sore throat 54–61–6
    Coryza 00–00–6
    Cough 00–00–5
    Fever 21–40–6
    Headache 30–40–6
    Muscle ache 30–40–6
    Temperature, ºC b 37.30.7035.8–39.5
    Centor score 32–31–4
    n %
    FeverPAIN total score 2 516.7
    3 1343.3
    4 826.7
    5 413.3
    Pharyngeal or tonsillar inflammation None 26.7
    Mild 413.3
    Moderate 1240.0
    Severe 1240.0
    Pharyngeal or tonsillar exudate or pus None 1653.3
    Mild 413.3
    Moderate 516.7
    Severe 516.7
    Enlargement of anterior cervical nodes None 516.7
    Mild 723.3
    Moderate 1550.0
    Severe 310.0
    Tenderness of anterior cervical nodes None 723.3
    Mild 310.0
    Moderate 1033.3
    Severe 1033.3
    Diabetes 413.3
    Obesity (BMI >30)516.7
    Chronic liver disease 00.0
    • BMI = body mass index.

    • aSeverity ratings: 1 = normal or not affected; 2 = very little problem; 3 = slight problem; 4 = moderately bad; 5 = bad; 6 = very bad; 7 = as bad as it could be. bValues are mean and standard deviation.

    • View popup
    Table 3. Calprotectin values (ng/ml) for cases and controls
    UntransformedNatural logarithm transformed
    Cases( n = 30)Controls( n = 10)Cases(n = 30)Controls( n = 10)
    Mean (ng/ml)41816.715591.519.807.84
    Standard deviation 51559.607877.321.401.53
    Median 17045.802849.289.747.91
    Lower to upper quartile 5983.85 to75835.501561.00 to6414.458.70 to11.247.35 to8.77
    Minimum to maximum 2057.60 to178115.5079.95 to26720.007.63 to12.094.38 to10.19
Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 4, Issue 2
June 2020
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
Behnaz Schofield, Clive Gregory, Micaela Gal, David Gillespie, Gurudutt Naik, Alastair Hay, Nick Francis
BJGP Open 2020; 4 (2): bjgpopen20X101006. DOI: 10.3399/bjgpopen20X101006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
Behnaz Schofield, Clive Gregory, Micaela Gal, David Gillespie, Gurudutt Naik, Alastair Hay, Nick Francis
BJGP Open 2020; 4 (2): bjgpopen20X101006. DOI: 10.3399/bjgpopen20X101006
del.icio.us logo Facebook logo Mendeley logo Bluesky logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • How this fits in
    • Introduction
    • Method
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • leukocyte L1 antigen complex
  • pharyngitis
  • anti-bacterial agents
  • group A streptococci
  • primary health care
  • calprotectin
  • sore throat
  • antibiotics

More in this TOC Section

  • Identifying and addressing UTI prevention barriers in primary care: a qualitative study
  • Depictions of the GP crisis: thematic analysis of UK newspapers pre-general election
  • Continuing professional development on planetary health for African family physicians: descriptive survey
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2025 BJGP Open

Online ISSN: 2398-3795